X-74531529-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_006517.5(SLC16A2):​c.1596C>T​(p.Ser532Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000843 in 1,207,168 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 313 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00055 ( 0 hom., 12 hem., cov: 23)
Exomes 𝑓: 0.00087 ( 0 hom. 301 hem. )

Consequence

SLC16A2
NM_006517.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.0880

Publications

0 publications found
Variant links:
Genes affected
SLC16A2 (HGNC:10923): (solute carrier family 16 member 2) This gene encodes an integral membrane protein that functions as a transporter of thyroid hormone. The encoded protein facilitates the cellular importation of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine (T2). This gene is expressed in many tissues and likely plays an important role in the development of the central nervous system. Loss of function mutations in this gene are associated with psychomotor retardation in males while females exhibit no neurological defects and more moderate thyroid-deficient phenotypes. This gene is subject to X-chromosome inactivation. Mutations in this gene are the cause of Allan-Herndon-Dudley syndrome. [provided by RefSeq, Mar 2012]
SLC16A2 Gene-Disease associations (from GenCC):
  • Allan-Herndon-Dudley syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant X-74531529-C-T is Benign according to our data. Variant chrX-74531529-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 167692.
BP7
Synonymous conserved (PhyloP=-0.088 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000553 (62/112067) while in subpopulation NFE AF = 0.00094 (50/53166). AF 95% confidence interval is 0.000733. There are 0 homozygotes in GnomAd4. There are 12 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 12 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006517.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
NM_006517.5
MANE Select
c.1596C>Tp.Ser532Ser
synonymous
Exon 6 of 6NP_006508.2P36021

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC16A2
ENST00000587091.6
TSL:1 MANE Select
c.1596C>Tp.Ser532Ser
synonymous
Exon 6 of 6ENSP00000465734.1P36021
SLC16A2
ENST00000878592.1
c.1710C>Tp.Ser570Ser
synonymous
Exon 7 of 7ENSP00000548651.1
SLC16A2
ENST00000922847.1
c.1674C>Tp.Ser558Ser
synonymous
Exon 7 of 7ENSP00000592906.1

Frequencies

GnomAD3 genomes
AF:
0.000554
AC:
62
AN:
112011
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000974
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000566
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000163
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000940
Gnomad OTH
AF:
0.00134
GnomAD2 exomes
AF:
0.000534
AC:
98
AN:
183361
AF XY:
0.000590
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.000182
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.00104
Gnomad OTH exome
AF:
0.00110
GnomAD4 exome
AF:
0.000873
AC:
956
AN:
1095101
Hom.:
0
Cov.:
29
AF XY:
0.000834
AC XY:
301
AN XY:
361123
show subpopulations
African (AFR)
AF:
0.000342
AC:
9
AN:
26338
American (AMR)
AF:
0.000341
AC:
12
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19376
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30201
South Asian (SAS)
AF:
0.0000740
AC:
4
AN:
54052
European-Finnish (FIN)
AF:
0.000123
AC:
5
AN:
40532
Middle Eastern (MID)
AF:
0.000311
AC:
1
AN:
3219
European-Non Finnish (NFE)
AF:
0.00108
AC:
907
AN:
840244
Other (OTH)
AF:
0.000392
AC:
18
AN:
45932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000553
AC:
62
AN:
112067
Hom.:
0
Cov.:
23
AF XY:
0.000350
AC XY:
12
AN XY:
34245
show subpopulations
African (AFR)
AF:
0.0000972
AC:
3
AN:
30860
American (AMR)
AF:
0.000566
AC:
6
AN:
10608
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3540
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2696
European-Finnish (FIN)
AF:
0.000163
AC:
1
AN:
6138
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000940
AC:
50
AN:
53166
Other (OTH)
AF:
0.00132
AC:
2
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000546
Hom.:
6
Bravo
AF:
0.000525
EpiCase
AF:
0.00180
EpiControl
AF:
0.00124

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
-
2
not specified (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
3.1
DANN
Benign
0.52
PhyloP100
-0.088
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199904356; hg19: chrX-73751364; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.